Donate
Join Us

Articles

Articles
September 28, 2021
Outcomes of a Marathon FDA Meeting on the Safety of Gene Replacement
Articles
September 24, 2021
Taysha Gene Therapies Shares Letter to the Rett Syndrome Community
Articles
September 23, 2021
Taysha Gene Therapies Announces Age Range For First Trial During Educational Rett Event for Investors
Articles
September 21, 2021
A Company working on a Rett Curative Therapy is Getting Backed by a Pharmaceutical Powerhouse
Articles
September 15, 2021
Hope Will Light the Way
Articles
September 3, 2021
First-Ever Rett Clinical Guidelines Help Us Anticipate Health Changes and Needs
Articles
September 3, 2021
Communication Tips for the New School Year
Articles
September 2, 2021
News from Taysha That We are One Step Closer to Testing Gene Replacement for Rett
Articles
July 29, 2021
A Reason to Celebrate: Children with a Severe Neurological Disorder Improve After Gene Replacement
Articles
July 10, 2021
Biopharma Tool Kit for Rett Syndrome Development Programs
Articles
July 8, 2021
Gene Replacement for Rett Syndrome 101
Articles
June 30, 2021
Cure 360 Webinar Series: Gene Replacement for Rett Syndrome 101
Articles
June 18, 2021
Developing an Epigenetic Therapeutic for MECP2 Reactivation
Articles
June 6, 2021
New Collaboration Intensifies Effort to Cure Rett Syndrome by Reactivating MECP2
Articles
June 3, 2021
In their own words - members of RSRT’s newly formed Translational Medicine Advisory Board share their reasons for optimism
Articles
May 26, 2021
Seven New RSRT-Supported Therapeutics Make Their Way Towards Clinical Trials
Articles
May 12, 2021
Introducing ACTX 101, a Gene Therapy for Rett Using X Reactivation Technology
Articles
April 26, 2021
Assessing Rett Symptoms with Cutting Edge Biosensors and Invisible Technology